2014
DOI: 10.1016/j.nano.2014.06.015
|View full text |Cite
|
Sign up to set email alerts
|

Effect of lipidated gonadotropin-releasing hormone peptides on receptor mediated binding and uptake into prostate cancer cells in vitro

Abstract: Word Count: 102Complete Manuscript Word Count: 5156 Number of Figures: 6 Number of Tables: 3 Number of References: 44Funding: We are grateful for funding provided by the NHMRC Program Grants (496600 and APP1037304). We also thank Thalia Guerin for her critical review of this manuscript. Conflict of

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
3
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 38 publications
2
3
0
Order By: Relevance
“…The addition of hydrophobic moieties (such as lipids) has been shown to increase nonspecific binding to the surface of cells, which could account for the higher level of cell-binding observed for 12 (Figure ). Here, nonspecific binding observed for peptide 12 could be associated with the affinity of the vaccine candidates for non-C-type lectin receptors (including Toll-like receptors) where previous studies on lipidated peptides have confirmed this finding . The mannan inhibition study indicated that receptor-mediated uptake through a mannan-inhibited receptor (e.g., MR) is likely.…”
Section: Results and Discussionsupporting
confidence: 51%
“…The addition of hydrophobic moieties (such as lipids) has been shown to increase nonspecific binding to the surface of cells, which could account for the higher level of cell-binding observed for 12 (Figure ). Here, nonspecific binding observed for peptide 12 could be associated with the affinity of the vaccine candidates for non-C-type lectin receptors (including Toll-like receptors) where previous studies on lipidated peptides have confirmed this finding . The mannan inhibition study indicated that receptor-mediated uptake through a mannan-inhibited receptor (e.g., MR) is likely.…”
Section: Results and Discussionsupporting
confidence: 51%
“…Figure 3-12 shows the RP-HPLC trace for construct 15 as an example. The peak of product (15, Figure 3-12) and the lipopeptide starting material (11, Figure 3-12) are multivalent because the lipids are present as a diastereomeric mixture in accordance to previous reports [255]. Construct 15 also contained a mixture of both α-and β-stereochemistries for the mannose units (Figure 3-11).…”
Section: Conjugation Of Mannosylated Peptide Azides To Lipopeptide Alsupporting
confidence: 73%
“…However, 16 that did not have any mannose units in its structure had a higher uptake than 13 or 14. The addition of hydrophobic moieties (such as lipids) has been shown to increase non-specific binding to the surface of cells, which could account for the higher level of cell-binding observed for 16 (Figure 4-1) [255]. The non-specific binding observed for peptide 16 could be associated with the affinity of the vaccine candidates for non-CLRs (including TLRs) as previous studies on lipidated peptides have confirmed this finding [178].…”
Section: Flow Cytometry Cell Uptake Studymentioning
confidence: 54%
“…For instance, applications of cyclic RGD peptides, cell-surface hormone receptors (LHRH receptor), and tumor vasculature antigens in chemotherapeutic delivery systems have shown promising results [163,164]. Intensive research into the development of selfassembled peptide delivery vehicles for active or passive targeting of chemotherapeutics has accelerated due to the peptides' desirable physicochemical properties and potential for tailoring to suit specific biological applications [26].…”
Section: Anticancer Drug Deliverymentioning
confidence: 99%
“…Developing peptidebased vaccines has been hampered by the need to display antigens in their native conformation and the use of immuno-adjuvants that only exhibit adjuvanting properties under specific circumstances [168]. Recently, several patents have been registered for the development of self-adjuvanting vaccines from self-assembled peptides [164,165]. These materials provide scaffolds that can accommodate multivalency and molecular specificity, and enable anable control over epitope position [169].…”
Section: Self-assembled Peptides For Vaccine Designmentioning
confidence: 99%